ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas.

This study investigates to what extent travellers returning to Sweden with traveller's diarrhoea carry ESBL in their stool. The isolates are examined further according to species, phenotype, antibiogram and whole genome sequencing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Antibiotic Resistant Infection Antibiotic Resistant Strain Traveler's Diarrhea

Sex eligibility

All sexes

Study type

Observational

Primary location

Oskar Ljungquist

Helsingborg, Skåne County, 25187, Sweden

About this study

Samples sent to the department of clinical microbiology in Lund, Sweden for culture of salmonella, shigella, yersinia or campylobacter are also cultured selectively for ESBL.

All patients are contacted by mail with the results. ESBL-positive patients are invited to submit further faecal cultures and blood samples during one year follow up time, to investigate how long the patient is colonized with ESBL.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Travellers diarrhoea
foreign traveller

Exclusion criteria

foreign traveller but no symptoms

Treatment and study plan

No intervention, observational

Other

See above

Primary outcomes

Proportion ESBL-colonized after one year.

Time frame: 1 year

Defined as a Positive ESBL-culture obtained 12 months after travel

Sponsors and collaborators

Lead sponsor

Lund University

Other

Registry information

Official study title

ESBL-producing Enterobacteriaceae in Patients With Traveller's Diarrhoea- a Prospective Cohort Study.

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: Mar 7, 2019
Registry last updated: Jul 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed